Xueying Sun

8.4k total citations
187 papers, 6.8k citations indexed

About

Xueying Sun is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xueying Sun has authored 187 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Molecular Biology, 57 papers in Cancer Research and 43 papers in Oncology. Recurrent topics in Xueying Sun's work include Cancer, Hypoxia, and Metabolism (33 papers), Angiogenesis and VEGF in Cancer (22 papers) and Hepatocellular Carcinoma Treatment and Prognosis (14 papers). Xueying Sun is often cited by papers focused on Cancer, Hypoxia, and Metabolism (33 papers), Angiogenesis and VEGF in Cancer (22 papers) and Hepatocellular Carcinoma Treatment and Prognosis (14 papers). Xueying Sun collaborates with scholars based in China, New Zealand and United States. Xueying Sun's co-authors include Hongchi Jiang, Shangha Pan, Haiquan Qiao, Xian Jiang, Geoffrey W. Krissansen, Jagat R. Kanwar, Xuesong Dong, Bo Zhai, Gang Tan and Changjun He and has published in prestigious journals such as Circulation, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Xueying Sun

182 papers receiving 6.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xueying Sun China	48	3.4k	1.7k	1.2k	833	829	187	6.8k
Melchiorre Cervello Italy	44	3.4k 1.0×	1.1k 0.6×	1.3k 1.1×	690 0.8×	555 0.7×	137	6.0k
Rongxin Zhang China	44	3.1k 0.9×	1.5k 0.9×	1.4k 1.1×	713 0.9×	1.3k 1.6×	242	6.3k
Yutaka Kohgo Japan	44	2.9k 0.8×	1.0k 0.6×	1.4k 1.2×	1.5k 1.8×	575 0.7×	243	7.4k
Qiang Xia China	44	3.5k 1.0×	1.6k 0.9×	769 0.6×	1.1k 1.3×	734 0.9×	264	6.4k
Hui Dong China	42	2.3k 0.7×	1.0k 0.6×	876 0.7×	751 0.9×	405 0.5×	225	5.6k
Xiangdong Wang China	47	3.3k 1.0×	992 0.6×	1.1k 0.9×	1.0k 1.2×	1.3k 1.6×	246	7.6k
Naoko Ohtani Japan	40	4.6k 1.3×	913 0.5×	1.6k 1.4×	1.5k 1.8×	1.4k 1.7×	76	8.3k
Xi Chen China	45	3.7k 1.1×	1.4k 0.8×	1.4k 1.2×	1.4k 1.6×	1.6k 1.9×	347	8.1k
Shailendra Giri United States	45	3.5k 1.0×	1.0k 0.6×	944 0.8×	820 1.0×	1.0k 1.2×	137	6.8k
Ann C. Williams United Kingdom	40	2.9k 0.8×	1.4k 0.8×	1.5k 1.2×	417 0.5×	532 0.6×	122	6.0k

Countries citing papers authored by Xueying Sun

Since Specialization

Citations

This map shows the geographic impact of Xueying Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueying Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueying Sun more than expected).

Fields of papers citing papers by Xueying Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueying Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueying Sun. The network helps show where Xueying Sun may publish in the future.

Co-authorship network of co-authors of Xueying Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Xueying Sun. A scholar is included among the top collaborators of Xueying Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueying Sun. Xueying Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sun, Xueying, Kaifeng Lin, Chuanqi Zhao, et al.. (2025). Schiff-Base porous film for NO2 detection to Enable monitoring of solid propellant aging. Journal of Photochemistry and Photobiology A Chemistry. 467. 116450–116450.

Sun, Xueying, et al.. (2024). Comprehensive Systematic Review of Poly-L-lactic Acid in Facial Clinical Application. Aesthetic Plastic Surgery. 48(23). 5115–5135. 4 indexed citations

Li, Weidong, Xuesong Dong, Changjun He, et al.. (2019). LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells. Journal of Experimental & Clinical Cancer Research. 38(1). 183–183. 162 indexed citations

Jiang, Wenjing, Guangxin Li, Weidong Li, et al.. (2018). Sodium orthovanadate overcomes sorafenib resistance of hepatocellular carcinoma cells by inhibiting Na+/K+-ATPase activity and hypoxia-inducible pathways. Scientific Reports. 8(1). 9706–9706. 26 indexed citations

Li, Ziyi, Yonggang Cao, Jingyan Zhang, et al.. (2018). DHA attenuates hepatic ischemia reperfusion injury by inhibiting pyroptosis and activating PI3K/Akt pathway. European Journal of Pharmacology. 835. 1–10. 53 indexed citations

Li, Peng, Yaling Yin, Tao Guo, et al.. (2016). Inhibition of Aberrant MicroRNA-133a Expression in Endothelial Cells by Statin Prevents Endothelial Dysfunction by Targeting GTP Cyclohydrolase 1 in Vivo. Circulation. 134(22). 1752–1765. 112 indexed citations

Li, Tao, Jingtao Zhong, Xiaofeng Dong, et al.. (2016). Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway. Oncology Reports. 35(6). 3614–3622. 28 indexed citations

Zhao, Dali, Bo Zhai, Changjun He, et al.. (2014). Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells. Cellular Signalling. 26(5). 1030–1039. 126 indexed citations

Zhai, Bo, Fengli Hu, Xian Jiang, et al.. (2014). Inhibition of Akt Reverses the Acquired Resistance to Sorafenib by Switching Protective Autophagy to Autophagic Cell Death in Hepatocellular Carcinoma. Molecular Cancer Therapeutics. 13(6). 1589–1598. 245 indexed citations

10.

Dong, Xiaofeng, Rui Li, Peng Xiu, et al.. (2014). Meloxicam Executes Its Antitumor Effects against Hepatocellular Carcinoma in COX-2- Dependent and -Independent Pathways. PLoS ONE. 9(3). e92864–e92864. 39 indexed citations

11.

Reddy, Shiva, et al.. (2014). Distribution of insulin mRNA transcripts within the human body. Biochemical and Biophysical Research Communications. 451(3). 425–430. 4 indexed citations

12.

Ma, Li, Guangxin Li, Huaqiang Zhu, et al.. (2014). 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2. Cancer Letters. 355(1). 96–105. 85 indexed citations

13.

Pan, Huayang, Yong Ma, Dawei Wang, et al.. (2013). Effect of IFN-α on KC and LIX expression: Role of STAT1 and its effect on neutrophil recruitment to the spleen after lipopolysaccharide stimulation. Molecular Immunology. 56(1-2). 12–22. 6 indexed citations

14.

Dong, Xuesong, Lele Lin, Xian Jiang, et al.. (2013). Up‐regulation of survivin by AKT and hypoxia‐inducible factor 1α contributes to cisplatin resistance in gastric cancer. FEBS Journal. 281(1). 115–128. 77 indexed citations

15.

He, Changjun, Haiquan Qiao, Xian Jiang, et al.. (2011). Downregulating hypoxia‐inducible factor‐2α improves the efficacy of doxorubicin in the treatment of hepatocellular carcinoma. Cancer Science. 103(3). 528–534. 54 indexed citations

16.

Kang, Kai, Hongchi Jiang, Mingyan Zhao, Xueying Sun, & Shangha Pan. (2010). [Protection of CSE/H2S system in hepatic ischemia reperfusion injury in rats].. PubMed. 48(12). 924–8. 7 indexed citations

17.

Kong, Rui, Bei Sun, Hongchi Jiang, et al.. (2009). Downregulation of nuclear factor-κB p65 subunit by small interfering RNA synergizes with gemcitabine to inhibit the growth of pancreatic cancer. Cancer Letters. 291(1). 90–98. 72 indexed citations

18.

Zhang, Feng, Liquan Tong, Haiquan Qiao, et al.. (2008). Taurine Attenuates Multiple Organ Injury Induced by Intestinal Ischemia Reperfusion in Rats. Journal of Surgical Research. 149(1). 101–109. 38 indexed citations

19.

Liu, Fengjun, Peijun Wang, Xian Jiang, et al.. (2008). Antisense hypoxia‐inducible factor 1α gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma. Cancer Science. 99(10). 2055–2061. 52 indexed citations

20.

Kanwar, Jagat R., et al.. (2003). Requirements for ICAM-1 immunogene therapy of lymphoma. Cancer Gene Therapy. 10(6). 468–476. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact